Dr Jimmy Kwok

    #Yogi #Dr Passionate about #YogaTherapy for those affected by Cancer                      Proudly supporting @maggiescentres UK                                Twitter: @Dryoga Website:www.dryoga.co.uk      

Yoga effective among women with lymphedema following breast or gynecological cancer

A self-administered questionnaire was sent to 247 potentially eligible women.  Over 27 types of CAM were reported, with use of a chi machine, vitamin E supplements, yoga, and meditation being the most commonly reported forms. The perceived effectiveness ratings (1-7 with 7=completely effective) of mainstream (mean±standard deviation (SD): 5.3±1.5) and CAM therapies (mean±SD: 5.2+1.6) were considered high. Conclusions: These results demonstrate that mainstream and CAM treatment use is common, varied, and considered to be effective among women with lymphedema following breast or gynecological cancer. Furthermore, it highlights the immediate need for larger prospective studies assessing the inter-relationship between the use of mainstream and CAM therapies for treatment success.


Posted 156 weeks ago

About the Author

Dr Jimmy kwok, PhD Jimmy is currently working for a private hospital group based in Harley Street, London UK as the Head of Oncology Service Line. In his role, he is responsible for the development and management of cancer services across the network of hospitals. Jimmy gained his MA in Natural Sciences from Emmanuel College, University of Cambridge and his doctorate degree in Clinical Oncology (Breast Cancer) at Imperial College, London. Jimmy has also interned at Harvard Medical School, Boston USA and the oncology Department at Great Ormond Street Hospital, London. He has practiced Ashtanga yoga for over a decade and has qualified by training at the Ashtanga Institute, Mysore located in India. He is a registered yoga teacher RYT200 with Yoga Alliance UK. He is also a keen advocate of the use of yoga for cancer patients and works closely with Maggie's Cancer Centers to promote its use in recovering cancer patients.

Professional Publications

1. FOXM1 confers acquired cisplatin resistance in breast cancer cells.  Mol Cancer Res; 8(1) January 2010.  Jimmy M-M. Kwok, Barrie Peck, Lara J Monteiro, Helma D.C. Schwenen, Julie Millour, R.Charles Coombes, Stephen S. Myatt, EW-F, Lam.

2. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.   Mol Cancer Ther. 2008 Jul;7(7):2022-32.  Jimmy M-M. Kwok.  SS, Myatt. CM, Marson RC, Coombes.  D, Constantinidou. EW-F, Lam.

3. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. 2009 Mar;8(3):582-91. Epub 2009 Mar 10.  McGovern UB, Francis RE, Peck B, Guest SK, Wang J, Myatt SS, Krol J, Jimmy M-M. Kwok , Polychronis A, Coombes RC, Lam EW.

4. Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk.  Oncogene. 2008 May 1;27(20):2929-33.  R, Schwab. R, Bussolari. O, Chayka. D, Corvetta. G, Santilli. Jimmy M-M. Kwok. GF, Amorotti. GP, Tonini. L, Iacoviello. R, Bertorelle. C, Menin. M, Hubank . B, Calabretta. A, Sala.

Dr Yoga™ does not have any intention to provide specific medical advice, but rather to provide cancer survivors and patients with information to better understand their health and their diagnosed conditions or disorders. All Content provided on or through the Site:

 (I) is provided for informational purposes only

(II) is not a substitute for professional medical advice, care, diagnosis or treatment

(III) is not designed to promote or endorse any medical practice, program or agenda or any medical tests, products or procedures.